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OBJECTIVEdThe aim of this study was to reexamine the neurocognitive function of a cohort
of young adults with early-onset type 1 diabetes and compare their cognitive function to a
matched control group. We also examined whether cognitive function was related to prospec-
tively obtained severe hypoglycemia history, long-term glycemic control, or severe diabetic
ketoacidosis.
RESEARCH DESIGN ANDMETHODSdTesting included Wechsler Intelligence Scale
for Children and Adults, Wechsler Memory Scale, Cattell Culture Fair Intelligence Test (CCFIT),
Wisconsin Card Sorting Test (WCST), youth and adult self-report, and Beck Depression In-
ventory. We tested 34 control subjects (mean6 SE, age 19.56 0.5 years) and 33 type 1 diabetic
subjects (age 19.36 0.5 years, age at type 1 diabetes onset 3.36 0.3 years, A1C from diagnosis
8.7 6 0.1%, and diabetes duration 16.0 6 0.5 years).
RESULTSdThere was no difference in full-scale IQ scores in type 1 diabetic and control
subjects (100.7 6 2.0 vs. 102.5 6 1.4). There was no difference between groups in memory
subtests or in reporting of emotional and behavioral difﬁculties. The type 1 diabetes group scored
lower on the CCFIT for ﬂuid intelligence compared with control subjects (P = 0.028) and also
scored lower on WCST with more perseverative errors (P = 0.002) and fewer categories com-
pleted (P = 0.022).
CONCLUSIONSdThese data suggest no difference in general intellectual ability, memory,
and emotional difﬁculties in our cohort of young adults with early-onset type 1 diabetes com-
pared with control subjects and no deterioration over time. There were, however, ﬁndings to
suggest subtle changes leading to poorer performance on complex tasks of executive function.
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The impact of type 1 diabetes on thedeveloping brain remains controver-sial. Earlier age of diabetes onset has
long been identiﬁed as one of the stron-
gest risk factors associated with cognitive
dysfunction, ranging from poorer perfor-
mance on general intellectual testing (1,2)
to speciﬁc deﬁcits with visuospatial tasks,
attention, and psychomotor efﬁciency.
The effect of early-onset diabetes, how-
ever, is confounded by the impact of re-
current severe hypoglycemia. Repeated
severe hypoglycemia has been reported
to adversely affect various cognitive do-
mains, in particular long-term memory,
attention, and verbal IQ, although this has
not been consistent across studies (3,4).
Moreover, many of these studies are limited
by their retrospective collection of hypogly-
cemia history.
We previously reported neurocogni-
tive outcomes in 84 children with early-
onset diagnosis of type 1 diabetes deﬁned
as type 1 diabetes onset before 6 years of
age (4). In that initial study, we compared
those subjects who had a history of early
severe hypoglycemia with those who
had a history of late severe hypoglycemia
and also compared those who had expe-
rienced severe hypoglycemia with peers
whohadnohistory of seizures. Surprisingly,
there were no group differences revealed on
intellectual, memory, or behavioral meas-
ures. Furthermore, there was no evidence
that episodes of seizure or coma, even those
occurring in early childhood, resulted in
broad cognitive dysfunction, nor was there
evidence of speciﬁc memory difﬁculties at
the time of testing.
In this study, we reevaluate the neu-
rocognitive function of the cohortdwith
onset of type 1 diabetes before age 6
yearsdnow that they are young adults.
This early-onset type 1 diabetes cohort
is unique in that all subjects were initially
recruited from a population-based cohort
and have been prospectively followed
from diagnosis with documentation of
hypoglycemia rates and other key clinical
data, including A1C, at regular 3-month
clinic visits.
Our aims were, ﬁrst, to determine
whether there had been any deteriora-
tion in neurocognitive function in this
population-based cohort of young adults
with early-onset type 1 diabetes over the
10 years since they were previously tested.
Second,we sought for theﬁrst time to com-
pare the neurocognitive outcomes of this
cohort to a group of age- and sex-matched
healthy young adults. Finally, we aimed to
determinewhether cognitive function in this
cohort of patients with early-onset type 1
diabetes was related to their severe hypogly-
cemia history, long-term glycemic control,
or history of severe diabetic ketoacidosis.
RESEARCH DESIGN AND
METHODSdPatients with early-onset
type 1 diabetes, deﬁned as onset of type
1 diabetes before age 6 years, attending
Princess Margaret Hospital and who had
been treated continuously at the centerwere
eligible for the original study. Princess
Margaret Hospital is the only pediatric di-
abetes referral center for the population of
Western Australia, and almost all children
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diagnosed with type 1 diabetes in the state
are registered and treated there. Previous
studies have shown that this center has
a case ascertainment close to 100%. All
patients have had ongoing prospective
documentation from diagnosis at 3-month
intervals of hypoglycemic events, diabetic
ketoacidosis, and glycemic control, mea-
sured by A1C. Severe hypoglycemia is
deﬁned as coma or seizure associated
with hypoglycemia. Patient data were col-
lected prospectively at routine clinic visits
every 3 months using a speciﬁcally de-
signed data collection form completed by a
limited number of physicians. The details
of data collection have been documented
previously (5). In summary, both patients
and parents were instructed on how to re-
cord details of the hypoglycemic event, in-
cluding blood glucose levels and response
to treatment. This information was subse-
quently reviewed by the clinician and if val-
idated, recorded on the data collection
form.
The original type 1 diabetes cohort
consisted of 84 children with early-onset
type 1 diabetes (4). This cohort included
children with a history of early severe hy-
poglycemia, deﬁned as severe hypoglyce-
mia occurring before the age of 6 years;
those with a history of late severe hypo-
glycemia, deﬁned as severe hypoglycemia
occurring after the age of 6 years; and those
with early-onset diabetes with no history of
severe hypoglycemia. Recruitment oc-
curred between 1999 and 2000, and neuro-
cognitive assessment was performed at the
mean age of 10.0 years (range 6–15 years).
Of these 84 subjects, 79 also went on to
have neuroimaging with magnetic reso-
nance imaging scans (6) and electroence-
phalograms.
Ten years later in 2009, we contacted
77 of these subjects (98%) for repeat neuro-
cognitive assessment, neuroimaging, and
electroencephalogram. Of those contacted,
33 (42%) subjects attended both neuro-
imaging and cognitive assessments. An
additional eight participants attended neu-
roimaging only. A total of seven patients
agreed to take part but did not attend three
appointments arranged; three patients re-
fused because of work or school commit-
ments. An additional 17 patients refused,
either with no reason given or because they
did not wish to take part in research; and 9
patients hadmoved, either interstate or to a
rural/remote area. In addition to the early-
onset type 1 diabetes cohort, 34 age- and
sex-matched siblings of patients with type
1 diabetes from the Western Australian
type 1 diabetes database were recruited as
control subjects. Control subjects reported
no signiﬁcant medical conditions and did
not have type 1 diabetes.
Procedures
Subjects attended for 1 day of neurocog-
nitive testing lastingw8 h. Tests were ad-
ministered by psychologists blind to the
subjects’ medical history. There were set
breaks for rest and meals. Blood glucose
levels were obtained on arrival and at 2-h
intervals for the type 1 diabetes cohort.
Levels were maintained between 4 and
15 mmol/L for the duration of neurocog-
nitive testing.
Neurocognitive measures
Wechsler Intelligence Scale for Chil-
dren and Wechsler Adult Intelligence
Scale. General intellectual ability was
measured using the Wechsler Intelli-
gence Scale for Children, Fourth Edition
(WISC-IV) (7) for subjects ,16 years
old and the Wechsler Adult Intelligence
Scale, Fourth Edition (WAIS-IV) (8) for
subjects aged $16 years. Eight core sub-
tests (block design, similarities, digit span,
coding, vocabulary, letter-number se-
quencing, matrix peasoning, and symbol
search) and two supplementary subtests
(picture completion, and information)
were administered. Full-scale IQ, verbal
comprehension, perceptual reasoning,
working memory, and processing speed
index scores were computed by combin-
ing age-scaled subtest scores. While the
WISC-IV and WAIS-IV are not entirely
comparable, the correlation for full scale
IQ scores between both tests is 0.91. This
suggests that they are measuring highly
similar constructs.
Wechsler Memory Scale. Memory was
measured using the Wechsler Memory
Scale, Fourth Edition (WMS-IV) (9). The
WMS-IV is an individually administered
battery that provides subtest and compos-
ite scores that are used to assess various
memory abilities in individuals aged 16–90.
The current study used three subtests
(logical memory, verbal paired associates,
and visual reproduction) administering
both immediate and delayed-recall com-
ponents. These subtests were used to
compute three index scores (auditory
memory, immediate memory, and delayed
memory).
While the WMS-IV is designed to
assess memory in individuals $16 years
old, subjects aged 14 and 15 years in the
current study were also assessed using this
task. Previous research by Paniak et al. (10)
assessed subjects aged 9–15 years on the
Wechsler Memory Scale–Revised and
found that this age-group had percentage
recall scores for the logical memory and
visual reproduction subtests similar to
adult percentage recall scores. Typically, in-
dividuals aged #16 years are assessed us-
ing the Children’s Memory Scale (CMS);
however, there are difﬁculties in transfer-
ring scores from the CMS to the WMS-IV
when calculating a group total. Correla-
tions between indexes on the CMS and
the WMS-IV differ greatly (range: r =
0.25–0.70). As a consequence, scaled scores
for seven subjects younger than the age of
16 were computed using normative data for
subjects aged 16 years.
Cattell Culture Fair Intelligence Test.
Fluid intelligence was measured using
the Cattell Culture Fair Intelligence Test
(CCFIT). The CCFIT assesses novel
problem-solving ability without relying
on the use of knowledge that is speciﬁc
to certain cultures. As a consequence, the
CCFIT aims to measure intelligence in-
dependent of cultural experience, educa-
tional level, or verbal ability. This is aided
by the task being largely nonverbal in
nature, reducing the bias that is often found
in more crystallized measures of ﬂuid in-
telligence. The task consists of four timed
subtestsdseries, classiﬁcations, matrices,
and conditionsdthat test subjects’ ability
to perceive the relationship betweenﬁgures
and shapes. Raw scores for each of the sub-
tests were converted into age-adjusted
scaled scores (11), which were used to
calculate a total score.
Wisconsin Card Sorting Test. The
Wisconsin Card Sorting Test (WCST)
(12) is a measure of executive function.
The WCST assesses the execution of func-
tions such as set-shifting, concept forma-
tion, and problem solving in response to
tester feedback. The subjects were presented
with four pictographic reference cards that
were different in color, form, and number.
Subjectswere then presentedwith a deck of
stimulus cards and asked to match each
card to one of the four reference cards in
whichever way they thought best. Without
being informed, the participant was re-
quired to match cards using the rules of
color, form, or number. Throughout the
test, the administrator provided feedback
to the subject, indicating to them whether
they were correct or incorrect. Once the
subject had achieved 10 correct matches
in a row, the matching rule was changed
without the subject’s knowledge. Psycho-
metric scores were generated from the
WCST, the primary score being the number
of perseverative errors made before the
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subject realizes that the matching-criterion
rule has changed.
Youth Self Report and Adult Self
Report. Aspects of adaptive functioning
and other behavioral problems were mea-
sured using the Achenbach Youth Self
Report (YSR) (13) and Adult Self Report
(ASR) (14). Subjects aged $18 years were
administered the ASR, whereas the YSR
was administered to subjects aged ,18
years. Both questionnaires consist of eight
indexes: anxious/depressed, attentionprob-
lems, withdrawn, aggressive behavior, so-
matic complaints, rule-breaking behavior,
thought problems, and intrusive behavior.
Scores on the separate indexes form inter-
nalizing and externalizing scores that were
used to calculate a total score.
Beck Depression Inventory. Symptoms
of depression were evaluated using the
Beck Depression Inventory, Second Edi-
tion (BDI-II) (15). The BDI-II is a 21-item
self-report questionnaire that assesses the
intensity of depression in both clinical
and normal population groups.
State-Trait Anxiety Index and State-
Trait Anxiety Index for Children. Anx-
iety was measured using the State-Trait
Anxiety Index (STAI) for subjects aged
.15 years and the State-Trait Anxiety In-
dex for Children (STAI-C) for subjects
aged#14 years (16,17). The STAI and the
STAI-C are self-report instruments that
measure and distinguish between both the
temporary condition of state anxiety and
the long-standing quality of trait anxiety.
Laboratory measurements
A1C was measured at each 3-month visit.
A1C was assessed by an agglutination in-
hibition immunoassay (Ames DCA 2000;
Bayer Ltd., Mishawaka, IN). The inter- and
intra-assay coefﬁcients of variationwere 2.5
and 2.3%, respectively.
Statistical analysis
Clinical characteristics of the groups were
compared using Student t test (mean 6
SE) for variables normally distributed.
RESULTS
Clinical characteristics
The clinical characteristics of the early-
onset type 1 diabetes cohort are shown in
Table 1. Subjects with early-onset type 1
diabetes who attended for follow-up neuro-
cognitive assessment did not differ from
those who did not participate in the follow-
up study with respect to age, duration of di-
abetes, mean A1C from diagnosis, or A1C at
their last visit. The proportion of subjects
with a history of early severe hypoglyce-
mia, late severe hypoglycemia, and no his-
tory of severe hypoglycemia did not differ
between those who attended and those
who did not.
Subjects who attended for follow-up
testing performed similarly to those who
did not attend on the Wechsler Intelli-
gence Scale for Children, Third Edition
(WISC-III); CMS; Achenbach child be-
havior checklist; and Children’s Depres-
sion Index at baseline testing. Both
groups were also similar in terms of gray
and white matter volumes and left and
right hippocampal volumes measured by
magnetic resonance imaging. The propor-
tion of subjects reported to have mesial
temporal sclerosis was also similar in
both groups (P = 0.44). The Index of Rel-
ative Socioeconomic Advantage and Dis-
advantage published by the Australia
Bureau of Statistics (18) was used to de-
termine the socioeconomic status of our
cohort. Almost half (45%) of the type 1
diabetes group were classiﬁed as being in
the highest quintile of least socioeco-
nomic disadvantage, with 6% being in
the lowest quintile or group of highest
disadvantage. This is in keeping with
our epidemiological studies showing
that the incidence of type 1 diabetes was
higher in higher socioeconomic groups
(19). Our control population was similar
to our type 1 diabetes cohort in terms of
socioeconomic status. Our type 1 diabe-
tes cohort was largely white with one sub-
ject of Indian descent. All of our control
subjects were white.
Cognitive tests
Table 2 shows scores from the cognitive
assessment for the early-onset type 1
diabetes cohort and control subjects.
There were 33 type 1 diabetic subjects
assessed at the mean age of 19.3 6 0.5
years. There were 34 age- and sex-matched
control subjects also assessed at the mean
age of 19.56 0.5 years. There was no dif-
ference in full-scale IQ scores in the type 1
diabetes cohort compared with control
subjects (100.7 6 2.0 vs. 102.5 6 1.4;
P = 0.466), nor were there any differences
on the four index scores of verbal compre-
hension, perceptual reasoning, working
memory, and processing speed (P = 0.971,
P = 0.504, P = 0.862, and P = 0.235, respec-
tively). There were no differences observed
between the type 1 diabetes group and con-
trol subjects with WMS-IV subtests of audi-
tory memory, immediate memory, and
delayed memory (P = 0.825, P = 0.757,
and P = 0.368, respectively).
The type 1 diabetes group scored lower
on the CCFIT compared with control sub-
jects (109.5 6 2.3 vs. 117.8 6 2.9; P =
0.028 with effect size of 20.53). With a
conservative Bonferroni correction, this
would just fail to reach the appropriate
level of signiﬁcance required. Nevertheless,
the effect size for the CCFIT is approxi-
mately seven times the mean effect size
for the null results. Moreover, the type 1
diabetes group also scored lower on the
WCST with more perseverative errors and
fewer completed categories than the con-
trol group (P = 0.002 and P = 0.022, re-
spectively), usually taken to be indicators of
processes related conceptually to ﬂuid in-
telligence.
There were no differences between
groups in reporting of emotional and
behavioral difﬁculties assessed by both
YSR and ASR (P = 0.947). There was also
no difference in reporting of depressive
Table 1dClinical characteristics of early-onset type 1 diabetes cohort
Clinical characteristic Type 1 diabetes
Type 1 diabetes
(did not participate
in follow-up study) P
Sample size (% of original cohort) 33 (42) 46 (58)
Age (years) 19.3 6 0.5 19.1 6 0.4 0.758
Male (%) 15 (45) 21 (46) 0.986
Duration of diabetes (years) 16.0 6 0.5 16.0 6 0.5 0.950
Mean A1C from diagnosis (%) 8.7 6 0.1 8.7 6 0.1 0.841
A1C at last visit (%) 8.8 6 0.3 8.8 6 0.2 0.874
Severe hypoglycemia historydsubjects
in each group (%)
Early severe hypoglycemia 6 (18) 13 (28) 0.301
Late severe hypoglycemia 14 (42) 20 (43) 0.926
Never had seizure/coma 13 (40) 13 (28) 0.299
Data are n (%) and mean 6 SE.
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symptoms between groups assessed by
BDI-II (P = 0.762). Scores for both state
and trait anxiety were also similar for
both groups (P = 0.909 and P = 0.737,
respectively).
Severe hypoglycemia
Results of the cognitive tests by history of
severe hypoglycemia are shown in Table 3.
There was no difference between the early,
late, and no history of severe hypoglyce-
mia groups in full-scale IQ scores and in-
dexes, memory subtests, and CCFIT
scores. The early severe hypoglycemia sub-
group did, however, complete fewer cate-
gories in theWCST compared with control
subjects (P = 0.028).
A1C
The mean A1C from diagnosis for the type
1 diabetes group was 8.7% (range 7.2–
10.2). There was no difference between
full-scale IQ scores for subjects in the high-
est A1C quartile or lowest A1C quartile
compared with control subjects (P =
0.519 and P = 0.918, respectively). In ad-
dition, there was no difference in full-scale
IQ scores or other neurocognitivemeasures
tested for subjects with a history of severe
diabetic ketoacidosis versus those with no
history of severe diabetic ketoacidosis.
Microvascular complications
Microvascular complications were assessed
in the type 1 diabetes group according to
standard clinical guidelines, including clin-
ical examination, annual retinal examina-
tion by an ophthalmologist, and annual
morning urine testing formicroalbuminuria.
At the last urinalysis, 3 of our 33 participants
had evidence of microalbuminuria. None
of the subjects had evidence of clinically
signiﬁcant diabetic retinopathy. The three
subjects with microalbuminuria did not
demonstrate poorer performance on the
cognitive tests.
Comparison with previous
WISC-III results
The mean full-scale IQ results for the
original type 1 diabetes cohort (n = 84)
was 104.3 6 1.3 on the WISC-III. For
the subset that attended for the follow-
up study (n = 33), their follow-up full-
scale IQ result was 100.76 2.01 on either
the WISC-IV or WAIS-IV compared with
the previous mean full-scale IQ result of
106.2 6 2.1 scored on the WISC-III 10
years earlier.
CONCLUSIONSdThis study is the
ﬁrst to examine a population-based co-
hort of children diagnosed with diabetes
before the age of 6 years and followed
longitudinally for w16 years from diag-
nosis and to have prospective documen-
tation of severe hypoglycemia history
collected in a rigorous and systematic
manner. Many previous studies have re-
lied on retrospective assessment. A1Cwas
also recorded from diagnosis, allowing,
for the ﬁrst time, an assessment of the effect
of glycemia during childhood on cognitive
development. We found no differences in
tests of general intellectual ability,memory,
and emotional difﬁculties compared with
age- and sex-matched healthy control sub-
jects. A history of early seizure or coma as-
sociated with hypoglycemia occurring
before the age of 6 years was not associated
with lower full-scale IQ scores in young
adults with early-onset type 1 diabetes.
Overall, these are reassuring ﬁndings for
families with young children with type 1
diabetes.
The type 1 diabetes group did, how-
ever, score lower on speciﬁc tests of ﬂuid
intelligence and complex tasks of executive
function. Northam et al. (20) also found
similar poorer performance on measures
of executive function andprocessing speed.
While processing speed has also been
linked to ﬂuid intelligence, the correspon-
dence between deﬁcits in the CCFIT and
the WCST suggests that the link has more
to do with executive functioning and, in
particular, the processes associated with
prefrontal cortex. Such cognitive processes
include inhibition, set-shifting, goal main-
tenance, and other processes considered
the foundations of ﬂuid intelligence. Exec-
utive functions allow individuals to per-
form behaviors that are independent and
self-serving. Such behaviors are needed in
situations where habitual behaviors and re-
sponses are not appropriate, such as mul-
titasking, deciding between two different
alternatives, and mental planning. It is in-
teresting to speculate on the impact that
defects in executive function may have for
diabetes self-care behaviors, particularly in
view of the increasing demands on patients
and the complexity of such care.
Executive function tasks appear to be
more signiﬁcantly affected in the early
severe hypoglycemia subgroup, suggesting
that there may be subtle developmental
changes in the frontal cortex. Our numbers,
Table 2dResults from neurocognitive tests
Type 1
diabetes Control P
Cohen d
effect size
Sample size 33 34
Age (years) 19.3 6 0.5 19.5 6 0.5 0.781
WISC-IV and WAIS-IV
Full-scale IQ 100.7 6 2.0 102.5 6 1.4 0.466 20.18
Verbal comprehension index 100.6 6 2.0 100.7 6 1.7 0.971 20.01
Perceptual reasoning index 100.3 6 2.0 102.1 6 1.6 0.504 20.17
Working memory index 100.9 6 2.4 101.4 6 1.9 0.862 20.04
Processing speed index 101.0 6 2.2 104.8 6 2.3 0.235 20.29
WMS-IV
Auditory memory index 102.6 6 3.0 103.4 6 2.1 0.825 20.05
Immediate memory index 101.0 6 3.0 102.2 6 2.3 0.757 20.08
Delayed memory index 99.9 6 3.2 103.0 6 2.5 0.368 20.19
CCFIT
CCFIT IQ 109.5 6 2.3 117.8 6 2.9 0.028* 20.53
WCST
Perseverative errors 19.2 6 2.1 11.1 6 1.3 0.002* 0.74
Completed categories 4.8 6 0.3 5.6 6 0.2 0.022* 20.58
YSR and ASR
Internalizing behaviors 53.3 6 1.3 52.0 6 1.6 0.534 0.15
Externalizing behaviors 48.8 6 1.6 50.9 6 1.7 0.389 20.22
YSR/ASR total 50.4 6 1.4 50.5 6 1.4 0.947 20.01
BDI-II
BDI-II total 5.3 6 1.0 5.8 6 0.9 0.762 20.09
STAI and STAI-C
State total 33.6 6 1.6 33.4 6 1.3 0.909 0.02
Trait total 34.0 6 1.4 34.8 6 1.5 0.737 20.10
Data are mean 6 SE. *Signiﬁcant results.
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however, are small in the early seizure
subgroup. Rovet andEhrlich (21) also dem-
onstrated poorer performance on the
WCST in the seizure group in their 7-year
follow-up study of children with type 1 di-
abetes. These ﬁndings suggest that a history
of early seizure may be associated with sub-
tle developmental changes, leading to
poorer performance on complex tasks of
executive function.
Both acute hyperglycemia (22) and
chronic hyperglycemia (23) have also
been implicated in causing cognitive dys-
function in children with type 1 diabetes.
In our group, we found no difference in
full-scale IQ in our subjects with higher
mean A1C or lower mean AIC compared
with control subjects, suggesting that
chronic hyperglycemia was not associated
with poorer general intellectual ability in
this cohort. This may be in part due to the
reasonably tight range of A1C for this co-
hort. The possibility that there is an inter-
action between glycemic control and severe
hypoglycemia cannot be discounted, but
larger prospective studies would be re-
quired to explore this issue.
For the type 1 diabetes cohort, when
comparing the full-scale IQ scores on
WISC-IV and WAIS-IV to the previous
results obtained from the WISC-III, there
appears to be a drop of 5.5 IQ points
on follow-up testing. This apparent de-
cline should be treated with caution. New
intelligence tests are restandardized so
that the population mean is set at 100
as a result of the Flynn effect (24), a phe-
nomenon where performance on intelli-
gence tests is improving on average by
w3–4 IQ points per decade (25). In prac-
tice, this means that the same level of per-
formance on a new version of a test will be
scaled to a lower IQ score. Taking into
account the Flynn effect, there is no sig-
niﬁcant deterioration in this cohort over
the 10 years (current 104.76 2.0 vs. pre-
vious 106.2 6 2.1; P = 0.150). We con-
clude that there was no deterioration in
full-scale IQ scores in our cohort after 10
years of childhood type 1 diabetes.
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